<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Wikawee Russameethum และ Karunrat Tewthanom. (2017) RISK-BENEFIT OF HIGH DOSE METFORMIN BEYOND CURRENT EVIDENCE BASED PHARMACOTHERAPY. &lt;i&gt;Thai Bulletin of Pharmaceutical Science (TBPS)&lt;/i&gt;, &lt;i&gt;12&lt;/i&gt;(1 (January-June)2017), 55-62.</APA><Chicago>Wikawee Russameethum และ Karunrat Tewthanom. "RISK-BENEFIT OF HIGH DOSE METFORMIN BEYOND CURRENT EVIDENCE BASED PHARMACOTHERAPY". Thai Bulletin of Pharmaceutical Science (TBPS)  12 (2017):55-62.</Chicago><MLA>Wikawee Russameethum และ Karunrat Tewthanom. RISK-BENEFIT OF HIGH DOSE METFORMIN BEYOND CURRENT EVIDENCE BASED PHARMACOTHERAPY. Faculty of Pharmacy, Silpakorn University:ม.ป.ท. 2017.</MLA></bibliography></xml>
